Luminary Therapeutics, Inc.

New Filing
CIK: 0001793860·Biotechnology·DELAWARE·Filed: Jan 8, 2025
Total Offering

$5,920,000

Amount Sold

$5,184,500

Investors

48

First Sale

Nov 20, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Jeff Liter
Related Person
John Wells
Related Person
James Haymaker
Related Person
Tracey Lodie
Related Person
Mark Chance
Related Person
Jeff Ross
Related Person

Company

Luminary Therapeutics, Inc.

1200 Washington Avenue South

Minneapolis, MN, 55415

612-309-7653

SEC Filing

0001437749-25-000739

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Luminary Therapeutics, Inc. Form D Filing — $5,920,000 | FilingFlow